Back to top
more

Thermo Fisher Scientific (TMO)

(Delayed Data from NYSE)

$536.87 USD

536.87
1,976,220

+5.01 (0.94%)

Updated Jul 10, 2024 04:00 PM ET

After-Market: $536.96 +0.09 (0.02%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.15%
2Buy17.88%
3Hold9.47%
4Sell5.14%
5Strong Sell2.57%
S&P50011.11%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

2-Buy of 5   2      

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth A Momentum B VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 39% (152 out of 250)

Industry: Medical - Instruments

Better trading starts here.

Zacks News

Thermo Fisher Scientific is a scientific instrument maker and a world leader in serving science. In Nov 2006, Thermo Fisher Scientific, Inc. was formed through the merger of Thermo Electron Corporation with Fisher Scientific International Inc. On Feb 3, 2014, Thermo Fisher acquired Life Technologies Corporation. Following the acquisition, the new reporting segments are: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Thermo Fisher Scientific (TMO) Earnings Expected to Grow: What to Know Ahead of Next Week's Release

Thermo Fisher (TMO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will Solid Consumables Drive Illumina's (ILMN) Q1 Earnings?

Despite ongoing customers' transition from HiSeq consumables to NovaSeq, Illumina's (ILMN) Q1 results are expected to gain from this high throughput suite.

Top Ranked Momentum Stocks to Buy for April 16th

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, April 16th

Can Medical Devices Strength Drive Abbott (ABT) Q1 Earnings?

Abbott (ABT) expects high single-digit growth in Medical Devices' sales in first-quarter 2019 and continued double-digit growth in certain sub-segments.

Will Abbott's (ABT) Steady Overall Growth Aid Q1 Earnings?

At the end of 2018, Abbott (ABT) posts some encouraging data, buoying investors' optimism on its Diabetes Care segment.

The Zacks Analyst Blog Highlights: Mastercard, Honeywell, Thermo Fisher, Cigna and Norfolk Southern

The Zacks Analyst Blog Highlights: Mastercard, Honeywell, Thermo Fisher, Cigna and Norfolk Southern

Zacks.com featured expert Kevin Matras highlights: SS&C Technologies, Thermo Fisher Scientific, Columbia Sportswear, Heidrick & Struggles International and Anthem

Zacks.com featured expert Kevin Matras highlights: SS &C Technologies, Thermo Fisher Scientific, Columbia Sportswear, Heidrick & Struggles International and Anthem

Thermo Fisher (TMO) Hits 52-Week High, Can the Run Continue?

Thermo Fisher (TMO) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.

Sweta Killa headshot

5 Top-Ranked Dividend Stocks That Ensure Solid Growth

Given a dovish Fed and bouts of market volatility, investors are in search of steady income with some aspect of growth.

Sweta Killa headshot

5 Top-Ranked Dividend Stocks That Ensure Solid Growth

Given a dovish Fed and bouts of market volatility, investors are in search of steady income with some aspect of growth.

Mark Vickery headshot

Top Analyst Reports for Mastercard, Honeywell & Thermo Fisher

Today's Research Daily features new research reports on 16 major stocks, including Mastercard (MA), Honeywell (HON) and Thermo Fisher (TMO).

Why Thermo Fisher (TMO) Could Beat Earnings Estimates Again

Thermo Fisher (TMO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

Thermo Fisher to Buy Brammer Bio, Tightens Gene Therapy Grip

On closure of the acquisition deal, Brammer Bio will be integral to Thermo Fisher's (TMO) pharma services business within its Laboratory Products and Services wing.

The Zacks Analyst Blog Highlights: Amazon, Berkshire Hathaway, Thermo Fisher, Square and Public Service

The Zacks Analyst Blog Highlights: Amazon, Berkshire Hathaway, Thermo Fisher, Square and Public Service

Semtech (SMTC) to Report Q4 Earnings: What's in the Offing?

Semtech's (SMTC) differentiated growth drivers and diversification strategy are likely to drive fiscal fourth-quarter results. However, exposure to seasonality and competition remain concerns.

Pacific Biosciences (PACB) Incurs Q4 Loss, Revenues Fall Y/Y

Pacific Biosciences' (PACB) dismal fourth-quarter 2018 results can be attributed to disappointing performance by the company's Product Revenue segment.

Roper (ROP) Sells Scientific Imaging Businesses to Teledyne

The divestment of Roper's (ROP) Scientific Imaging businesses is in sync with its inorganic growth strategy.

The Zacks Analyst Blog Highlights: Boeing, Thermo Fisher, Anthem, PayPal and Pfizer

The Zacks Analyst Blog Highlights: Boeing, Thermo Fisher, Anthem, PayPal and Pfizer

Mark Vickery headshot

Top Analyst Reports for Boeing, Thermo Fisher & Anthem

Today's Research Daily features new research reports on 16 major stocks, including Boeing (BA), Thermo Fisher (TMO) and Anthem (ANTM).

Thermo Fisher (TMO) Beats on Earnings and Revenues in Q4

Thermo Fisher (TMO) gains on growth in all business segments in Q4.

Thermo Fisher Scientific (TMO) Tops Q4 Earnings and Revenue Estimates

Thermo Fisher (TMO) delivered earnings and revenue surprises of 1.88% and 4.32%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?

Thermo Fisher (TMO) Down on Business Divestment Declaration

Thermo Fisher's (TMO) Anatomical Pathology business comes under its Specialty Diagnostics segment catering to customers at healthcare and clinical laboratories.

Will Overall Growth Aid Thermo Fisher's (TMO) Q4 Earnings?

Thermo Fisher (TMO) rides high on a steadily strong analytical instrument business, flaunting robust global demand.

Thermo Fisher Scientific (TMO) Earnings Expected to Grow: Should You Buy?

Thermo Fisher (TMO) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Will Thermo Fisher (TMO) Beat Estimates Again in Its Next Earnings Report?

Thermo Fisher (TMO) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.